Evidence map›Paper›PMID 33671631›Full record

ArticleMicroorganisms2021

Genomic Epidemiology of SARS-CoV-2 in Madrid, Spain, during the First Wave of the Pandemic: Fast Spread and Early Dominance by D614G Variants.

Esther Viedma, Elias Dahdouh, José María González-Alba, Sara González-Bodi, Laura Martínez-García, Fernando Lázaro-Perona, Raúl Recio, María Rodríguez-Tejedor, María Dolores Folgueira, Rafael Cantón and 5 more

Abstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Esther ViedmaServicio de Microbiología, Hospital Universitario 12 de Octubre and Instituto de Investigación Hospital 12 de Octubre (imas12), 28009 Madrid, Spain.
Elias DahdouhServicio de Microbiología, Hospital Universitario La Paz and Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), 28046 Madrid, Spain.
José María González-AlbaServicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
Sara González-BodiServicio de Microbiología, Hospital Universitario 12 de Octubre and Instituto de Investigación Hospital 12 de Octubre (imas12), 28009 Madrid, Spain.
Laura Martínez-GarcíaServicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
Fernando Lázaro-PeronaServicio de Microbiología, Hospital Universitario La Paz and Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), 28046 Madrid, Spain.
Raúl RecioServicio de Microbiología, Hospital Universitario 12 de Octubre and Instituto de Investigación Hospital 12 de Octubre (imas12), 28009 Madrid, Spain.ORCID 0000-0003-0654-1679
María Rodríguez-TejedorServicio de Microbiología, Hospital Universitario La Paz and Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), 28046 Madrid, Spain.
María Dolores FolgueiraServicio de Microbiología, Hospital Universitario 12 de Octubre and Instituto de Investigación Hospital 12 de Octubre (imas12), 28009 Madrid, Spain.
Rafael CantónServicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.ORCID 0000-0003-1675-3173
Rafael DelgadoServicio de Microbiología, Hospital Universitario 12 de Octubre and Instituto de Investigación Hospital 12 de Octubre (imas12), 28009 Madrid, Spain.ORCID 0000-0002-6912-4736
Julio García-RodríguezServicio de Microbiología, Hospital Universitario La Paz and Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), 28046 Madrid, Spain.
Juan Carlos GalánServicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
Jesús MingoranceServicio de Microbiología, Hospital Universitario La Paz and Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), 28046 Madrid, Spain.ORCID 0000-0001-6173-5711
On Behalf Of The Sars-CoV-Working Groups

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in Madrid, Spain, on 25 February 2020. It increased in frequency very fast and by the end of May more than 70,000 cases had been confirmed by reverse transcription-polymerase chain reaction (RT-PCR). To study the lineages and the diversity of the viral population during this first epidemic wave in Madrid we sequenced 224 SARS-CoV-2 viral genomes collected from three hospitals from February to May 2020. All the known major lineages were found in this set of samples, though B.1 and B.1.5 were the most frequent ones, accounting for more than 60% of the sequences. In parallel with the B lineages and sublineages, the D614G mutation in the Spike protein sequence was detected soon after the detection of the first coronavirus disease 19 (COVID-19) case in Madrid and in two weeks became dominant, being found in 80% of the samples and remaining at this level during all the study periods. The lineage composition of the viral population found in Madrid was more similar to the European population than to the publicly available Spanish data, underlining the role of Madrid as a national and international transport hub. In agreement with this, phylodynamic analysis suggested multiple independent entries before the national lockdown and air transportation restrictions.

Indexed as

COVID-19genome sequencesSARS-CoV-2

Identifiers

PMID33671631
PMCPMC7926973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.